Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity RARE - Ultragenyx Pharmaceutical Inc.
1.5 B
LAST VALUE
-1.37%
2 YEAR CAGR
5.77%
5 YEAR CAGR
22.48%
10 YEAR CAGR